
Mary M. Barna, PharmD
Advertisement
Articles by Mary M. Barna, PharmD


Alzheimer's disease represents a mounting public health problem and clinicians need a strong understanding of both the disease and its various treatment modalities.

When discussing overactive bladder disease with a patient, the pharmacist needs to be sensitive to this treatable but often embarrassing medical condition.
Advertisement
Latest Updated Articles
Managing Opioid- Induced ConstipationSeptember 15th 2009
Alzheimer's Disease: Slowing Down the CourseMarch 1st 2009
Overactive Bladder Disease: Overcoming the Urge to GoJanuary 1st 2009
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
3
Beyond Weight Loss: Exploring the Renal and Anti-Inflammatory Benefits of High-Dose Semaglutide
4
New Research Suggests Bempedoic Acid Outperforms Ezetimibe for Heart Health in Patients with Type 2 Diabetes
5